⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL1729011 | 0.83 | — | — | |
| Phosphonic Acid SCHEMBL28728596 | 0.73 | — | — | |
| Phosphonic Acid SCHEMBL27775878 | 0.70 | — | — | |
| Phosphonic Acid SCHEMBL9753443 | 0.70 | — | — | |
| Phosphonic Acid SCHEMBL9239010 | 0.70 | — | — | |
| Phosphonic Acid SCHEMBL28360410 | 0.68 | — | — | |
| Phosphonic Acid SCHEMBL11044913 | 0.68 | — | — | |
| Phosphonic Acid SCHEMBL30849604 | 0.68 | — | — | |
| Phosphonic Acid SCHEMBL29523497 | 0.68 | — | — | |
| Phosphonic Acid SCHEMBL28550339 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250101006-A1 | PROCESS FOR THE SYNTHESIS OF PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2025-03-27 | — | — | US | disclosed |
| EP-4472969-A1 | PROCESS FOR THE SYNTHESIS OF PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS | Novartis AG (CH) | 2024-12-11 | — | — | EP | disclosed |
| CN-118871436-A | Synthesis of pyrazolyl derivatives useful as anticancer agents | 诺华股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| WO-2023143605-A1 | PROCESS FOR THE SYNTHESIS OF PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2023-08-03 | — | — | WO | disclosed |
| EP-3297991-B1 | NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES | SUN PHARMA ADVANCED RES CO LTD (IN) | 2020-01-29 | — | — | EP | disclosed |
| US-10150733-B2 | Amidoheteroaryl aroyl hydrazide ethynes | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2018-12-11 | — | — | US | disclosed |
| US-20180127372-A1 | NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2018-05-10 | — | — | US | disclosed |
| EP-3297991-A1 | NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES | Sun Pharma Advanced Research Company Ltd (IN) | 2018-03-28 | — | — | EP | disclosed |
| EP-2665709-B1 | DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS | SUN PHARMA ADVANCED RES CO LTD (IN) | 2016-12-07 | — | — | EP | disclosed |
| WO-2016185490-A1 | NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2016-11-24 | — | — | WO | disclosed |
| US-20070172832-A1 | Phosphonate fluorescent dyes and conjugates | EPOCH BIOSCIENCES, INC. (US) | 2007-07-26 | — | — | US | disclosed |
| US-20070093506-A1 | Inhibitors of tyrosine kinases | BREITENSTEIN WERNER | 2007-04-26 | — | — | US | disclosed |
| US-7169791-B2 | Inhibitors of tyrosine kinases | NOVARTIS AG (CH) | 2007-01-30 | — | — | US | disclosed |
| US-20060167015-A1 | 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol1yl)-3-(trifluoromethyl)phenyl]benzamide or an N-oxide or salts; anticarcinogenic agent (leukaemia) | NOVARTIS AG (CH) | 2006-07-27 | — | — | US | disclosed |
| US-20060142577-A1 | Novel pyrimidineamide derivatives and the use thereof | NOVARTIS AG (CH) | 2006-06-29 | — | — | US | disclosed |
| EP-1546127-A1 | NOVEL PYRIMIDINEAMIDE DERIVATIVES AND THE USE THEREOF | Novartis AG (CH) | 2005-06-29 | — | — | EP | disclosed |
| EP-1532138-A1 | INHIBITORS OF TYROSINE KINASES | Novartis AG (CH) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004029038-A1 | NOVEL PYRIMIDINEAMIDE DERIVATIVES AND THE USE THEREOF | NOVARTIS AG (CH) | 2004-04-08 | — | — | WO | disclosed |
| WO-2004005281-A1 | INHIBITORS OF TYROSINE KINASES | NOVARTIS AG (CH) | 2004-01-15 | — | — | WO | disclosed |
| WO-1998038168-A1 | ISOQUINOLINONE DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | TANABE SEIYAKU CO., LTD. (JP) | 1998-09-03 | — | — | WO | disclosed |